Delivery Order SPE2DB20D2104-SPE2DB25FNBKN
- Not listed
- The Defense Logistics Agency awarded a $6,081.01 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a pharmaceutical product for diabetes management. This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $3,095.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract, which was not set aside and competitively awarded, was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,140.05 to AmerisourceBergen Drug Corp for 180-count tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was awarded on September 11, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on August 27, 2025, with a ceiling value of $1,535.39 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBKNDelivery Order
The Defense Logistics Agency awarded a $1,006.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Janumet 50-1,000 mg, a pharmaceutical product used in diabetes management. The contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Medical Supply Chain leverages this contract vehicle to fulfill critical pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/23/25 |